TABLE 2.
Group | ND | HFD | Solvent | HFD+0.25% ATX | HFD+0.5% ATX | HFD+0.75% ATX |
Heart (g) | 0.15 ± 0.01a | 0.18 ± 0.03a | 0.16 ± 0.01a | 0.16 ± 0.02a | 0.16 ± 0.03a | 0.14 ± 0.01a |
Liver (g) | 1.12 ± 0.07a | 1.37 ± 0.02c | 1.39 ± 0.08c | 1.29 ± 0.06bc | 1.27 ± 0.03b | 1.23 ± 0.07b |
Spleen (g) | 0.07 ± 0.01a | 0.08 ± 0.02a | 0.08 ± 0.02a | 0.07 ± 0.01a | 0.07 ± 0.02a | 0.08 ± 0.01a |
Kidney (g) | 0.34 ± 0.02a | 0.42 ± 0.05a | 0.43 ± 0.04a | 0.40 ± 0.04a | 0.39 ± 0.04a | 0.36 ± 0.03a |
Visceral adipose tissue (g) | 0.63 ± 0.20a | 2.17 ± 0.60c | 2.03 ± 0.66c | 1.84 ± 0.34c | 1.78 ± 0.37c | 1.15 ± 0.20b |
aAll values are expressed as the mean ± SD (n = 6). Mean separation was performed using Duncan’s multiple range test. The different letters (a–c) indicate significant differences (P < 0.05). The visceral adipose tissue included perirenal adipose and epididymal adipose.